Exemestane

Especificaciones

107868-30-4Número CAS

643-090-2Número CE

(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dioneNombre IUPAC

C20H24O2Fórmula química

296.4 g/molPeso molecular

EXEMESTANE; 107868-30-4; Aromasin; 6-Methyleneandrosta-1,4-diene-3,17-dione; Exemestano; FCE-24304; Exemestanum; Androsta-1,4-diene-3,17-dione, 6-methylene-; DTXSID5023037; FCE24304; PNU-155971; NY22HMQ4BX; NSC713563; NSC-758907; CHEBI:4953; DTXCID003037; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione; examestane; (1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-diene-5,14-dione; (1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,14-dione; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta(a)phenanthrene-3,17-dione; RefChem:57964; L02BG06; Fce 24304; Exemestanum [INN-Latin]; Exemestano [INN-Spanish]; 6-Methylene-androsta-1,4-diene-3,17-dione; C20H24O2; Exemestan; Exemestane (Standard); 6-Methylenandrosta-1,4-diene-3,17-dione; Aromasine; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione; (8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione; Aromasil; 6-methylideneandrosta-1,4-diene-3,17-dione; Exemestane [USAN:INN:BAN]; Nikidess; (8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione; Aromasin (TN); SMR000466314; CAS-107868-30-4; HSDB 7463; Curator_000009; UNII-NY22HMQ4BX; Exemestane (JAN/USP/INN); CCRIS 9351; Aromasin;; Exemestane CRS; NCGC00095289-01; Androsta-1,4-diene-3,17-dione, 6-methylene-; 6-Methyleneandrosta-1,4-diene-3,17-dione; Aromasil; Aromasin; Exemestane; FCE 24304; Exemestane [INN]; Exemestane; aromasin; Exemestane, Aromasin; PNU 155971; EXEMESTANE [MI]; EXEMESTANE [JAN]; EXEMESTANE [HSDB]; EXEMESTANE [USAN]; EXEMESTANE [VANDF]; EXEMESTANE [MART.]; SCHEMBL6215; Aromasin (Pharmacia Upjohn); EXEMESTANE [USP-RS]; EXEMESTANE [WHO-DD]; Exemestane(FCE 24304); MLS000759419; MLS001424062; orb315348; Exemestane(FCE 24304)?; GTPL7073; 6-Methylenandrosta-1,17-dione; CHEMBL1200374; EXEMESTANE [ORANGE BOOK]; Exemestane, >=98% (HPLC); EXEMESTANE [EP MONOGRAPH]; EXEMESTANE [USP MONOGRAPH]; GLXC-06573; HMS2051J04; HMS3713H12; MSK10960; Tox21_111499; BDBM50398447; HY-13632R; MFCD00866994; s1196; Exemestane for system suitability CRS; AKOS015840113; AKOS015895161; Tox21_111499_1; AC-2171; CCG-100995; CS-1766; DB00990; FM23211; KS-5136; NC00245; NSC 758907; NSC-713563; NCGC00271596-03; NCGC00271596-13; (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione; 6-methylenandrost-1,4-dien-3,17-dione; AS-31053; CPD000466314; HY-13632; 6-Methylen-androst-1,4-diene-3,17-dione; CS-0694867; E0941; E9317; NS00000304; C08162; D00963; AB00639936-06; AB00639936-08; AB00639936-09; AB00639936-10; AB00639936_11; Q418819; SR-01000759393; SR-01000759393-4; BRD-K33425534-001-12-5; Exemestane, European Pharmacopoeia (EP) Reference Standard; Exemestane, United States Pharmacopeia (USP) Reference Standard; Exemestane, Pharmaceutical Secondary Standard; Certified Reference Material; Exemestane for system suitability, European Pharmacopoeia (EP) Reference Standard; EXMSinónimos